National Health Investors (NHI) Is a Great Momentum Stock: Should You Buy?
National Health Investors Price Target Raised to $78.00/Share From $65.00 by Truist Securities
National Health Investors Analyst Ratings
Deutsche Bank Maintains National Health Investors Inc(NHI.US) With Buy Rating, Raises Target Price to $90
Deutsche Bank Raises Price Target on National Health Investors to $90 From $69, Keeps Buy Rating
Wells Fargo Maintains National Health Investors Inc(NHI.US) With Buy Rating, Raises Target Price to $81
KeyBanc Initiates National Health Investors Inc(NHI.US) With Hold Rating
KeyBanc Sticks to Their Hold Rating for National Health Investors (NHI)
Four REIT Stocks Pass a Strict Quality Screen, With Dividend Yields up to 6.19%
Office REITs Find an Open Door in the Bond Market
Titan Machinery Reports Weak Preliminary Results, Joins Precigen, Gogoro And Other Big Stocks Moving Lower In Thursday Pre-Market Session
National Health Investors Prices Stock Offering at $71.25 Per Share
Reported Earlier, National Health Investors Prices Upsized Public Offering of 2.4M Common Shares At $71.25/Shares
NHI Announces Pricing of Upsized Public Offering of Common Stock
NHI Announces Public Offering of Common Stock
Express News | National Health Investors Commenced Underwritten Public Offering Of 2M Shares
Mortgage Applications Rocket By 16.8%, Notch Strongest Weekly Increase In 1.5 Years: 'Homebuyers Took The Opportunity To Refinance'
REITs Keep Reducing NAV Discount Amid an Impending Rally
Buy Rating Justified by National Health Investors' Strong Q2 Financials and Growth Prospects
Express News | National Health Investors Inc : Wedbush Raises Target Price to $87 From $73